To evaluate the efficacy and safety of subcutaneous and intravenous abatacept.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Abatacept (Primary) ; Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 22 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Mar 2014 New trial record